Improving Regulatory Transparency for New Medical Therapies Act
Latest action · Nov 25, 2015 Became Public Law No: 114-89.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 2, 2015
- Passed HouseMar 16, 2015
- Passed SenateOct 26, 2015
- To the PresidentNov 19, 2015
- Became lawNov 25, 2015Public Law 114-89
Summary
(This measure has not been amended since it was passed by the Senate on October 26, 2015. The summary of that version is repeated here.)
Improving Regulatory Transparency for New Medical Therapies Act
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the drug. This delay also applies to conditional approval and indexing of animal drugs.
This bill amends the Controlled Substances Act to require the DOJ to issue a final interim rule for a drug product recommended for controls by the FDA not later than 90 days after DOJ receives a recommendation for controls or the FDA approves the drug. The final interim rule is effective immediately.
For purposes of submitting an application to extend a patent, a drug product recommended for controls is considered to be approved and have permission for commercial marketing and use on the date of FDA approval or the date an interim final rule is issued, whichever is later.
(Sec. 3) Timelines are established for DOJ to either register an applicant to manufacture a controlled substance for a clinical trial or serve an order to show cause upon the applicant.
(Sec. 4) This bill amends the Controlled Substances Import and Export Act to allow exported controlled substances to be re-exported within the European Economic Area.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Feb 2, 2015 to Mar 16, 2015; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NJ | Frank Pallone, Jr. | Original | Feb 2, 2015 |
| D-TX | Gene Green | Original | Feb 2, 2015 |
| R-WA | Cathy McMorris Rodgers | Mar 16, 2015 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 2, 2015Reported Mar 16, 2015 |
| Health Subcommittee | Referred Feb 6, 2015 | |
| House | Judiciary Committee | Referred Feb 2, 2015Discharged Mar 16, 2015 |
| Crime and Federal Government Surveillance Subcommittee | Referred Feb 3, 2015 | |
| Senate | Health, Education, Labor, and Pensions Committee | Referred Mar 17, 2015Discharged Oct 26, 2015 |
Actions 24
Everything that happened, newest first.
- Nov 25, 2015Signed by President.
- Nov 25, 2015Became Public Law No: 114-89.
- Nov 19, 2015Presented to President.
- Nov 16, 2015Mr. Griffith asked unanimous consent that the House agree to the Senate amendment. (consideration: CR H8212-8213)
- Nov 16, 2015Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection. (text as House agreed to Senate amendment: CR H8212-8213)
- Nov 16, 2015Motion to reconsider laid on the table Agreed to without objection.
- Oct 27, 2015Message on Senate action sent to the House.
- Oct 26, 2015Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S7495)
- Oct 26, 2015Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S7495)
- Oct 26, 2015Measure laid before Senate by unanimous consent. (consideration: CR S7495)
- Oct 26, 2015Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
- Mar 17, 2015Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Mar 16, 2015Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-41, Part I.
- Mar 16, 2015Committee on the Judiciary discharged.
- Mar 16, 2015Placed on the Union Calendar, Calendar No. 26.
- Mar 16, 2015Mr. Pitts moved to suspend the rules and pass the bill, as amended.
- Mar 16, 2015Considered under suspension of the rules. (consideration: CR H1638-1641)
- Mar 16, 2015DEBATE - The House proceeded with forty minutes of debate on H.R. 639.
- Mar 16, 2015Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H1638-1639)
- Mar 16, 2015Motion to reconsider laid on the table Agreed to without objection.
- Feb 6, 2015Referred to the Subcommittee on Health.
- Feb 3, 2015Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Feb 2, 2015Introduced in House
- Feb 2, 2015Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H8212, H8213Text printed H8212Amendments H8212 | H. Morgan Griffith R-VA | Nov 16, 2015 |
| Senate | Debate and remarks S7495Amendments S7494 | Lamar Alexander R-TN (amendment), Rob Portman R-OH | Oct 26, 2015 |
| House | Debate and remarks H1638–H1641Text printed H1638Cost estimates H1641 | Frank Pallone, Jr. D-NJ, Gene Green D-TX, Joseph R. Pitts R-PA, Michael C. Burgess R-TX | Mar 16, 2015 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Mar 17, 2015H.R. 639, Improving Regulatory Transparency for New Medical Therapies ActAs ordered reported by the House Committee on Energy and Commerce on February 12, 2015
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 161, no. 17, February 2, 2015, page H704.
CRS reports 9
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 9
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R45472 | Market-Based Greenhouse Gas Emission Reduction Legislation: 108th Through 118th Congresses Archived | Report | Dec 4, 2024 |
| R47561 | Greenhouse Gas Emissions in the U.S. Electricity Sector: Background, Policies, and Projections | Report | May 18, 2023 |
| R47385 | U.S. Greenhouse Gas Emissions Trends and Projections from the Inflation Reduction Act Archived | Report | Jan 12, 2023 |
| R44782 | The Evolution of Marijuana as a Controlled Substance and the Federal-State Policy Gap | Report | Apr 7, 2022 |
| IN11682 | Drug Enforcement Administration Set to Increase Registered Marijuana Manufacturers for Research Purposes Archived | Insight | May 25, 2021 |
Amendments 1
Amendments offered to this bill.
| Amendment | Description | Offered by | Status |
|---|---|---|---|
| SA 2748 | In the nature of a substitute. | Lamar Alexander R-TNfor Rob Portman | Amendment SA 2748 agreed to in Senate by Unanimous Consent. |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 481 | Improving Regulatory Transparency for New Medical Therapies Act | Related bill | Oct 1, 2015 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.
- Short Titles as Introduced
- Improving Regulatory Transparency for New Medical Therapies Act
- Short Titles as Passed House
- Improving Regulatory Transparency for New Medical Therapies Act
- Short Titles as Passed Senate
- Improving Regulatory Transparency for New Medical Therapies Act
- Short Titles as Enacted
- Improving Regulatory Transparency for New Medical Therapies Act
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 6
Each version as it was printed, newest first.
- —Enrolled Bill
- Oct 26, 2015Engrossed Amendment Senate
- Mar 17, 2015Referred in Senate
- Mar 16, 2015Engrossed in House
- Mar 16, 2015Reported in House
- Feb 2, 2015Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.